Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.43994111 |
2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.34047745 |
3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.22680994 |
4 | muscle filament sliding (GO:0030049) | 5.20963008 |
5 | actin-myosin filament sliding (GO:0033275) | 5.20963008 |
6 | plasma membrane repair (GO:0001778) | 5.02660524 |
7 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.02377487 |
8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.96232298 |
9 | sarcomere organization (GO:0045214) | 4.83864730 |
10 | regulation of skeletal muscle contraction (GO:0014819) | 4.80543447 |
11 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.75262377 |
12 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.61930388 |
13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.55090245 |
14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.50316268 |
15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.49000635 |
16 | synaptic vesicle maturation (GO:0016188) | 4.41476265 |
17 | regulation of cell communication by electrical coupling (GO:0010649) | 4.40351180 |
18 | myofibril assembly (GO:0030239) | 4.38423672 |
19 | cardiac muscle contraction (GO:0060048) | 4.33601932 |
20 | cardiac myofibril assembly (GO:0055003) | 4.33289654 |
21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.27781209 |
22 | striated muscle contraction (GO:0006941) | 4.21225462 |
23 | tricarboxylic acid cycle (GO:0006099) | 4.21135194 |
24 | actin-mediated cell contraction (GO:0070252) | 4.16578591 |
25 | cell communication by electrical coupling (GO:0010644) | 4.11783913 |
26 | regulation of membrane repolarization (GO:0060306) | 4.08077199 |
27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.03904542 |
28 | neuronal action potential propagation (GO:0019227) | 4.03402260 |
29 | response to muscle activity (GO:0014850) | 4.00586365 |
30 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.94500873 |
31 | skeletal muscle fiber development (GO:0048741) | 3.85267328 |
32 | skeletal muscle contraction (GO:0003009) | 3.85117922 |
33 | regulation of synapse structural plasticity (GO:0051823) | 3.81936753 |
34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.81213708 |
35 | locomotory exploration behavior (GO:0035641) | 3.76367348 |
36 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.71095746 |
37 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.71095746 |
38 | cell communication involved in cardiac conduction (GO:0086065) | 3.68545116 |
39 | regulation of relaxation of muscle (GO:1901077) | 3.66998584 |
40 | regulation of actin filament-based movement (GO:1903115) | 3.66207534 |
41 | myotube cell development (GO:0014904) | 3.64467561 |
42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.64234092 |
43 | vocalization behavior (GO:0071625) | 3.57766711 |
44 | muscle fiber development (GO:0048747) | 3.57196063 |
45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.55136269 |
46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.54706191 |
47 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.53445471 |
48 | glutamate secretion (GO:0014047) | 3.53093936 |
49 | sodium ion export (GO:0071436) | 3.52858237 |
50 | synaptic vesicle exocytosis (GO:0016079) | 3.52492329 |
51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.51112645 |
52 | potassium ion import (GO:0010107) | 3.45539352 |
53 | regulation of cofactor metabolic process (GO:0051193) | 3.40531099 |
54 | regulation of coenzyme metabolic process (GO:0051196) | 3.40531099 |
55 | membrane depolarization during action potential (GO:0086010) | 3.38148343 |
56 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.37173541 |
57 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.36679168 |
58 | muscle hypertrophy (GO:0014896) | 3.35934351 |
59 | cellular potassium ion homeostasis (GO:0030007) | 3.35505026 |
60 | actomyosin structure organization (GO:0031032) | 3.32217980 |
61 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.31922607 |
62 | activation of protein kinase A activity (GO:0034199) | 3.29763842 |
63 | muscle tissue morphogenesis (GO:0060415) | 3.29073871 |
64 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.28974687 |
65 | regulation of the force of heart contraction (GO:0002026) | 3.27115414 |
66 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.26484961 |
67 | carnitine shuttle (GO:0006853) | 3.24886421 |
68 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.21836766 |
69 | striated muscle adaptation (GO:0014888) | 3.21692666 |
70 | regulation of striated muscle contraction (GO:0006942) | 3.21032103 |
71 | detection of calcium ion (GO:0005513) | 3.19538539 |
72 | negative regulation of potassium ion transport (GO:0043267) | 3.18670670 |
73 | gluconeogenesis (GO:0006094) | 3.18113773 |
74 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.17230725 |
75 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.16483793 |
76 | actin filament-based movement (GO:0030048) | 3.15314563 |
77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11715143 |
78 | cardiac muscle hypertrophy (GO:0003300) | 3.10814744 |
79 | neurotransmitter secretion (GO:0007269) | 3.09606596 |
80 | regulation of synaptic vesicle transport (GO:1902803) | 3.09328745 |
81 | striated muscle hypertrophy (GO:0014897) | 3.06619000 |
82 | postsynaptic membrane organization (GO:0001941) | 3.06229556 |
83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.05324803 |
84 | neuromuscular synaptic transmission (GO:0007274) | 3.05313954 |
85 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.05172480 |
86 | cardiac muscle cell action potential (GO:0086001) | 3.04205477 |
87 | muscle contraction (GO:0006936) | 3.02974363 |
88 | striated muscle cell development (GO:0055002) | 3.02421745 |
89 | regulation of cation channel activity (GO:2001257) | 3.02405303 |
90 | cardiac conduction (GO:0061337) | 3.02097994 |
91 | NADH metabolic process (GO:0006734) | 3.00231234 |
92 | cardiac muscle cell development (GO:0055013) | 2.99841942 |
93 | proline transport (GO:0015824) | 2.99509926 |
94 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.97259382 |
95 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.97077692 |
96 | glycogen catabolic process (GO:0005980) | 2.96091541 |
97 | heart process (GO:0003015) | 2.95389732 |
98 | heart contraction (GO:0060047) | 2.95389732 |
99 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.95043103 |
100 | muscle hypertrophy in response to stress (GO:0003299) | 2.95043103 |
101 | cardiac muscle adaptation (GO:0014887) | 2.95043103 |
102 | skeletal muscle adaptation (GO:0043501) | 2.94836724 |
103 | glucan biosynthetic process (GO:0009250) | 2.93594154 |
104 | glycogen biosynthetic process (GO:0005978) | 2.93594154 |
105 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93392265 |
106 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.92866213 |
107 | response to inactivity (GO:0014854) | 2.91429146 |
108 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.91384202 |
109 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.91384202 |
110 | positive regulation of cation channel activity (GO:2001259) | 2.90721326 |
111 | skeletal muscle tissue development (GO:0007519) | 2.87400340 |
112 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.85715454 |
113 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.82466917 |
114 | myotube differentiation (GO:0014902) | 2.82230811 |
115 | positive regulation of potassium ion transport (GO:0043268) | 2.81271388 |
116 | hexose biosynthetic process (GO:0019319) | 2.80662173 |
117 | muscle structure development (GO:0061061) | 2.79675606 |
118 | relaxation of muscle (GO:0090075) | 2.79639115 |
119 | muscle organ development (GO:0007517) | 2.78317870 |
120 | regulation of transmembrane transporter activity (GO:0022898) | 2.77474500 |
121 | cardiac cell development (GO:0055006) | 2.76556109 |
122 | muscle system process (GO:0003012) | 2.76192920 |
123 | aspartate family amino acid catabolic process (GO:0009068) | 2.75795352 |
124 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.75631737 |
125 | regulation of sarcomere organization (GO:0060297) | 2.74990429 |
126 | adult heart development (GO:0007512) | 2.74502836 |
127 | layer formation in cerebral cortex (GO:0021819) | 2.74169277 |
128 | creatine metabolic process (GO:0006600) | 2.73337754 |
129 | glucan catabolic process (GO:0009251) | 2.73188344 |
130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72983703 |
131 | muscle cell fate commitment (GO:0042693) | 2.71647080 |
132 | protein localization to synapse (GO:0035418) | 2.71621895 |
133 | regulation of ATP catabolic process (GO:1903289) | 2.69568476 |
134 | regulation of ATPase activity (GO:0043462) | 2.69568476 |
135 | relaxation of cardiac muscle (GO:0055119) | 2.66778491 |
136 | cellular polysaccharide catabolic process (GO:0044247) | 2.64045000 |
137 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.62523618 |
138 | myoblast fusion (GO:0007520) | 2.62350655 |
139 | muscle cell development (GO:0055001) | 2.62277892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.36218473 |
2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.95256907 |
3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.70032777 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.66877918 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62497552 |
6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50371243 |
7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.46304755 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46116039 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46116039 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30063673 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26578815 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25221028 |
13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21727405 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19512882 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17189355 |
16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16249454 |
17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11595360 |
18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11343951 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08886679 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08606772 |
21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.96768686 |
22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94946151 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93510182 |
24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85187262 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83468427 |
26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.83177273 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81234221 |
28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.73174102 |
29 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.72763852 |
30 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.70285118 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69918880 |
32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63405797 |
33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59176763 |
34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58587612 |
35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55642756 |
36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54892781 |
37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45580509 |
38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45022418 |
39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43805056 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42288282 |
41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41654017 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41486566 |
43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40894503 |
44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38704251 |
45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38542204 |
46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38542204 |
47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37398764 |
48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36387779 |
49 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.34687769 |
50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33740432 |
51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30177326 |
52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29476437 |
53 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.28262478 |
54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26536454 |
55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24960365 |
56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24313622 |
57 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24300036 |
58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24269422 |
59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24236449 |
60 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22768984 |
61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18073239 |
62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17552114 |
63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17376707 |
64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16270315 |
65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14751557 |
66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14430410 |
67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13958269 |
68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12767842 |
69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12649126 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11732806 |
71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09722153 |
72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09679895 |
73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09248159 |
74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08827271 |
75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08275816 |
76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06240913 |
77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03911296 |
78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03592459 |
79 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03245148 |
80 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02951476 |
81 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02940869 |
82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02773352 |
83 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.02312503 |
84 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02092288 |
85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02010267 |
86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01220048 |
87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00989770 |
88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00793582 |
89 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99512180 |
90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99086143 |
91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98968675 |
92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98787458 |
93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97053478 |
94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96646845 |
95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95734637 |
96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95389281 |
97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95000546 |
98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94701570 |
99 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94432588 |
100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93970940 |
101 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93439143 |
102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93399806 |
103 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92292841 |
104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91324878 |
105 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.90793054 |
106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90617915 |
107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90357770 |
108 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88033073 |
109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87858631 |
110 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87820218 |
111 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87022269 |
112 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86336068 |
113 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85336378 |
114 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85271963 |
115 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85248292 |
116 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85007666 |
117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84877446 |
118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84816283 |
119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83734392 |
120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83696791 |
121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83376173 |
122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83233984 |
123 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.81494656 |
124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81119738 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80845527 |
126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80760088 |
127 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.80754704 |
128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80669690 |
129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80640601 |
130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80439559 |
131 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80190068 |
132 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79535494 |
133 | FUS_26573619_Chip-Seq_HEK293_Human | 0.79299785 |
134 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79192201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 4.72361238 |
2 | MP0000751_myopathy | 4.66072824 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 4.57940889 |
4 | MP0004859_abnormal_synaptic_plasticity | 3.97081837 |
5 | MP0004145_abnormal_muscle_electrophysio | 3.92966253 |
6 | * MP0000749_muscle_degeneration | 3.35772257 |
7 | MP0004036_abnormal_muscle_relaxation | 3.26986950 |
8 | MP0004084_abnormal_cardiac_muscle | 3.22287151 |
9 | MP0004215_abnormal_myocardial_fiber | 3.20459628 |
10 | MP0004270_analgesia | 2.56707623 |
11 | MP0003635_abnormal_synaptic_transmissio | 2.48505615 |
12 | MP0000747_muscle_weakness | 2.43692377 |
13 | * MP0004087_abnormal_muscle_fiber | 2.40159471 |
14 | * MP0002106_abnormal_muscle_physiology | 2.35179570 |
15 | MP0005620_abnormal_muscle_contractility | 2.34015867 |
16 | MP0004130_abnormal_muscle_cell | 2.33533297 |
17 | MP0002269_muscular_atrophy | 2.29689728 |
18 | MP0005330_cardiomyopathy | 2.27833535 |
19 | MP0003880_abnormal_central_pattern | 2.22301909 |
20 | MP0009046_muscle_twitch | 2.15914074 |
21 | MP0003137_abnormal_impulse_conducting | 2.15604339 |
22 | * MP0000759_abnormal_skeletal_muscle | 2.10168608 |
23 | * MP0005369_muscle_phenotype | 1.98012598 |
24 | MP0004233_abnormal_muscle_weight | 1.97589203 |
25 | MP0009745_abnormal_behavioral_response | 1.97366205 |
26 | MP0002822_catalepsy | 1.97074686 |
27 | MP0002972_abnormal_cardiac_muscle | 1.94102230 |
28 | MP0002064_seizures | 1.88311324 |
29 | MP0002063_abnormal_learning/memory/cond | 1.87690090 |
30 | MP0004484_altered_response_of | 1.86431851 |
31 | MP0004858_abnormal_nervous_system | 1.66429768 |
32 | MP0004085_abnormal_heartbeat | 1.66156064 |
33 | MP0002909_abnormal_adrenal_gland | 1.63761259 |
34 | MP0002272_abnormal_nervous_system | 1.60182133 |
35 | MP0008775_abnormal_heart_ventricle | 1.57920487 |
36 | * MP0000750_abnormal_muscle_regeneration | 1.56746035 |
37 | MP0002734_abnormal_mechanical_nocicepti | 1.54632271 |
38 | MP0002572_abnormal_emotion/affect_behav | 1.52948936 |
39 | MP0001486_abnormal_startle_reflex | 1.41386398 |
40 | MP0001968_abnormal_touch/_nociception | 1.40157756 |
41 | * MP0008569_lethality_at_weaning | 1.39657490 |
42 | MP0005385_cardiovascular_system_phenoty | 1.37860332 |
43 | MP0001544_abnormal_cardiovascular_syste | 1.37860332 |
44 | MP0009780_abnormal_chondrocyte_physiolo | 1.37816589 |
45 | MP0006036_abnormal_mitochondrial_physio | 1.37378760 |
46 | MP0005451_abnormal_body_composition | 1.35998666 |
47 | MP0010630_abnormal_cardiac_muscle | 1.35923935 |
48 | MP0006138_congestive_heart_failure | 1.31412285 |
49 | MP0005423_abnormal_somatic_nervous | 1.31034081 |
50 | MP0001440_abnormal_grooming_behavior | 1.30722341 |
51 | MP0006035_abnormal_mitochondrial_morpho | 1.24257175 |
52 | MP0008961_abnormal_basal_metabolism | 1.23340508 |
53 | MP0002067_abnormal_sensory_capabilities | 1.23266478 |
54 | * MP0002332_abnormal_exercise_endurance | 1.20389316 |
55 | MP0000013_abnormal_adipose_tissue | 1.17274734 |
56 | MP0005386_behavior/neurological_phenoty | 1.15252755 |
57 | MP0004924_abnormal_behavior | 1.15252755 |
58 | MP0001501_abnormal_sleep_pattern | 1.14485118 |
59 | MP0001299_abnormal_eye_distance/ | 1.14288368 |
60 | MP0004043_abnormal_pH_regulation | 1.13771657 |
61 | MP0002638_abnormal_pupillary_reflex | 1.11910417 |
62 | MP0003329_amyloid_beta_deposits | 1.09452394 |
63 | MP0002108_abnormal_muscle_morphology | 1.07129581 |
64 | MP0001970_abnormal_pain_threshold | 1.05489024 |
65 | MP0002127_abnormal_cardiovascular_syste | 1.05084354 |
66 | MP0010030_abnormal_orbit_morphology | 1.04460506 |
67 | MP0002733_abnormal_thermal_nociception | 1.04439661 |
68 | MP0002736_abnormal_nociception_after | 1.01907233 |
69 | MP0004811_abnormal_neuron_physiology | 0.99384336 |
70 | MP0002735_abnormal_chemical_nociception | 0.98936970 |
71 | MP0003136_yellow_coat_color | 0.97280569 |
72 | MP0002184_abnormal_innervation | 0.96431091 |
73 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95525292 |
74 | MP0004510_myositis | 0.95306545 |
75 | MP0002066_abnormal_motor_capabilities/c | 0.94932018 |
76 | MP0005187_abnormal_penis_morphology | 0.94592623 |
77 | MP0004142_abnormal_muscle_tone | 0.94228539 |
78 | MP0002234_abnormal_pharynx_morphology | 0.92143170 |
79 | MP0000955_abnormal_spinal_cord | 0.90702820 |
80 | MP0003633_abnormal_nervous_system | 0.90368911 |
81 | MP0005623_abnormal_meninges_morphology | 0.90163212 |
82 | MP0003122_maternal_imprinting | 0.87410607 |
83 | MP0005171_absent_coat_pigmentation | 0.86724088 |
84 | MP0001661_extended_life_span | 0.86451284 |
85 | MP0002557_abnormal_social/conspecific_i | 0.82644238 |
86 | MP0004147_increased_porphyrin_level | 0.79910201 |
87 | MP0001984_abnormal_olfaction | 0.79181756 |
88 | MP0002882_abnormal_neuron_morphology | 0.77668387 |
89 | MP0005666_abnormal_adipose_tissue | 0.77071224 |
90 | MP0005646_abnormal_pituitary_gland | 0.76120466 |
91 | MP0003879_abnormal_hair_cell | 0.75586030 |
92 | MP0000372_irregular_coat_pigmentation | 0.75245768 |
93 | MP0004885_abnormal_endolymph | 0.71174355 |
94 | MP0005535_abnormal_body_temperature | 0.69070057 |
95 | MP0000579_abnormal_nail_morphology | 0.68368893 |
96 | MP0001502_abnormal_circadian_rhythm | 0.67972794 |
97 | MP0003631_nervous_system_phenotype | 0.66853172 |
98 | MP0008874_decreased_physiological_sensi | 0.66603262 |
99 | MP0000778_abnormal_nervous_system | 0.63659647 |
100 | MP0005375_adipose_tissue_phenotype | 0.63494513 |
101 | MP0003283_abnormal_digestive_organ | 0.62385895 |
102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.60165447 |
103 | MP0005167_abnormal_blood-brain_barrier | 0.59660345 |
104 | MP0000733_abnormal_muscle_development | 0.59398947 |
105 | MP0004185_abnormal_adipocyte_glucose | 0.59303233 |
106 | MP0000762_abnormal_tongue_morphology | 0.58613433 |
107 | MP0002229_neurodegeneration | 0.58402660 |
108 | MP0000003_abnormal_adipose_tissue | 0.58328226 |
109 | MP0001529_abnormal_vocalization | 0.58257030 |
110 | MP0006276_abnormal_autonomic_nervous | 0.57723109 |
111 | * MP0005266_abnormal_metabolism | 0.57538121 |
112 | MP0001346_abnormal_lacrimal_gland | 0.57343146 |
113 | MP0003828_pulmonary_edema | 0.56964591 |
114 | MP0003385_abnormal_body_wall | 0.55660491 |
115 | * MP0000266_abnormal_heart_morphology | 0.55333282 |
116 | MP0002971_abnormal_brown_adipose | 0.54738123 |
117 | MP0003705_abnormal_hypodermis_morpholog | 0.53971230 |
118 | MP0000534_abnormal_ureter_morphology | 0.53601370 |
119 | MP0005670_abnormal_white_adipose | 0.52603103 |
120 | MP0009672_abnormal_birth_weight | 0.51947015 |
121 | MP0002152_abnormal_brain_morphology | 0.51027075 |
122 | MP0002752_abnormal_somatic_nervous | 0.49497523 |
123 | MP0001943_abnormal_respiration | 0.48984591 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 6.98349217 |
2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.52835672 |
3 | Calf muscle hypertrophy (HP:0008981) | 5.45626925 |
4 | Sudden death (HP:0001699) | 5.19377035 |
5 | * Exercise-induced muscle cramps (HP:0003710) | 5.08422419 |
6 | Muscle fiber inclusion bodies (HP:0100299) | 4.83457502 |
7 | Difficulty running (HP:0009046) | 4.66673801 |
8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.64348611 |
9 | Abnormality of the calf musculature (HP:0001430) | 4.35835475 |
10 | Muscle fiber splitting (HP:0003555) | 4.33412680 |
11 | Hyporeflexia of lower limbs (HP:0002600) | 4.16126709 |
12 | Nemaline bodies (HP:0003798) | 4.09773276 |
13 | EMG: myopathic abnormalities (HP:0003458) | 4.04004960 |
14 | Type 1 muscle fiber predominance (HP:0003803) | 4.03706639 |
15 | Focal motor seizures (HP:0011153) | 3.89573545 |
16 | * Myoglobinuria (HP:0002913) | 3.81486789 |
17 | Increased connective tissue (HP:0009025) | 3.63298101 |
18 | Ventricular tachycardia (HP:0004756) | 3.62794625 |
19 | Bundle branch block (HP:0011710) | 3.60011605 |
20 | Atrial fibrillation (HP:0005110) | 3.56090070 |
21 | Subaortic stenosis (HP:0001682) | 3.49861154 |
22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.49861154 |
23 | Distal arthrogryposis (HP:0005684) | 3.48677875 |
24 | Muscle stiffness (HP:0003552) | 3.42429336 |
25 | Primary atrial arrhythmia (HP:0001692) | 3.40531558 |
26 | Deformed tarsal bones (HP:0008119) | 3.37680346 |
27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.32625860 |
28 | Supraventricular tachycardia (HP:0004755) | 3.25891974 |
29 | Myopathic facies (HP:0002058) | 3.24943587 |
30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.20634472 |
31 | Ventricular fibrillation (HP:0001663) | 3.18140552 |
32 | Supraventricular arrhythmia (HP:0005115) | 3.17274344 |
33 | Myokymia (HP:0002411) | 3.16994184 |
34 | * Myotonia (HP:0002486) | 3.11693456 |
35 | Round ear (HP:0100830) | 3.06743102 |
36 | Visual hallucinations (HP:0002367) | 3.06232680 |
37 | Prolonged QT interval (HP:0001657) | 2.99400654 |
38 | Difficulty climbing stairs (HP:0003551) | 2.98082446 |
39 | Rhabdomyolysis (HP:0003201) | 2.97649994 |
40 | Syncope (HP:0001279) | 2.90356611 |
41 | Asymmetric septal hypertrophy (HP:0001670) | 2.85766089 |
42 | Focal seizures (HP:0007359) | 2.84612873 |
43 | Ventricular arrhythmia (HP:0004308) | 2.82929880 |
44 | Heart block (HP:0012722) | 2.73021794 |
45 | Dysmetric saccades (HP:0000641) | 2.66400291 |
46 | Abnormal EKG (HP:0003115) | 2.64844962 |
47 | Generalized muscle weakness (HP:0003324) | 2.57384374 |
48 | EMG: neuropathic changes (HP:0003445) | 2.57311993 |
49 | Abnormal atrioventricular conduction (HP:0005150) | 2.57005931 |
50 | Lipoatrophy (HP:0100578) | 2.56650235 |
51 | Atonic seizures (HP:0010819) | 2.51202428 |
52 | Ulnar deviation of the wrist (HP:0003049) | 2.47588499 |
53 | Neck muscle weakness (HP:0000467) | 2.46722509 |
54 | Abnormal finger flexion creases (HP:0006143) | 2.45639586 |
55 | Abnormality of the lower motor neuron (HP:0002366) | 2.43724749 |
56 | Pheochromocytoma (HP:0002666) | 2.42643019 |
57 | Scapular winging (HP:0003691) | 2.41674234 |
58 | Febrile seizures (HP:0002373) | 2.40262399 |
59 | Palpitations (HP:0001962) | 2.39098380 |
60 | Epileptic encephalopathy (HP:0200134) | 2.37469511 |
61 | Atrioventricular block (HP:0001678) | 2.35656412 |
62 | Malignant hyperthermia (HP:0002047) | 2.33925733 |
63 | Abnormality of the foot musculature (HP:0001436) | 2.32859484 |
64 | Generalized tonic-clonic seizures (HP:0002069) | 2.30139970 |
65 | Right ventricular cardiomyopathy (HP:0011663) | 2.29676159 |
66 | Dilated cardiomyopathy (HP:0001644) | 2.28625949 |
67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27321621 |
68 | Rimmed vacuoles (HP:0003805) | 2.26508070 |
69 | Abnormality of the calcaneus (HP:0008364) | 2.23956988 |
70 | Absence seizures (HP:0002121) | 2.22248174 |
71 | Lower limb amyotrophy (HP:0007210) | 2.18578404 |
72 | Limb-girdle muscle atrophy (HP:0003797) | 2.18168628 |
73 | Areflexia of lower limbs (HP:0002522) | 2.17425143 |
74 | Left ventricular hypertrophy (HP:0001712) | 2.14766879 |
75 | Frequent falls (HP:0002359) | 2.12261737 |
76 | Neuroendocrine neoplasm (HP:0100634) | 2.11821242 |
77 | Poor eye contact (HP:0000817) | 2.11432420 |
78 | Depression (HP:0000716) | 2.11137427 |
79 | Spinal rigidity (HP:0003306) | 2.11028530 |
80 | Foot dorsiflexor weakness (HP:0009027) | 2.10753619 |
81 | Distal lower limb amyotrophy (HP:0008944) | 2.10199920 |
82 | Shoulder girdle muscle weakness (HP:0003547) | 2.08449359 |
83 | Dysdiadochokinesis (HP:0002075) | 2.07707748 |
84 | Dialeptic seizures (HP:0011146) | 2.06481100 |
85 | Resting tremor (HP:0002322) | 2.06407132 |
86 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.05592084 |
87 | Action tremor (HP:0002345) | 2.05383638 |
88 | Ankle clonus (HP:0011448) | 2.03070359 |
89 | Broad-based gait (HP:0002136) | 2.03027384 |
90 | Fetal akinesia sequence (HP:0001989) | 2.02508858 |
91 | Progressive muscle weakness (HP:0003323) | 2.02427780 |
92 | Abnormal social behavior (HP:0012433) | 2.01919520 |
93 | Impaired social interactions (HP:0000735) | 2.01919520 |
94 | Testicular atrophy (HP:0000029) | 2.01394674 |
95 | Limb-girdle muscle weakness (HP:0003325) | 1.99485662 |
96 | Bulbar palsy (HP:0001283) | 1.99145463 |
97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.97829919 |
98 | Calcaneovalgus deformity (HP:0001848) | 1.95783804 |
99 | Weak cry (HP:0001612) | 1.94901166 |
100 | Proximal amyotrophy (HP:0007126) | 1.94439702 |
101 | Rapidly progressive (HP:0003678) | 1.94272753 |
102 | Slender build (HP:0001533) | 1.93010887 |
103 | Muscular dystrophy (HP:0003560) | 1.92215873 |
104 | Ragged-red muscle fibers (HP:0003200) | 1.92109076 |
105 | Achilles tendon contracture (HP:0001771) | 1.89987099 |
106 | Distal lower limb muscle weakness (HP:0009053) | 1.88925778 |
107 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87572024 |
108 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.86674473 |
109 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.86674473 |
110 | Urinary urgency (HP:0000012) | 1.85818378 |
111 | Anxiety (HP:0000739) | 1.83915659 |
112 | Gowers sign (HP:0003391) | 1.83722973 |
113 | Hamartoma of the eye (HP:0010568) | 1.83010475 |
114 | Absent phalangeal crease (HP:0006109) | 1.82854815 |
115 | Progressive cerebellar ataxia (HP:0002073) | 1.82631590 |
116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82622690 |
117 | Hyperkalemia (HP:0002153) | 1.81471478 |
118 | Hip contracture (HP:0003273) | 1.77701889 |
119 | Steppage gait (HP:0003376) | 1.75741736 |
120 | Abnormality of the neuromuscular junction (HP:0003398) | 1.75410693 |
121 | Fatigable weakness (HP:0003473) | 1.75410693 |
122 | Abnormality of glycolysis (HP:0004366) | 1.73760327 |
123 | Pelvic girdle muscle weakness (HP:0003749) | 1.72566305 |
124 | Waddling gait (HP:0002515) | 1.70526601 |
125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.62768710 |
126 | * Exercise intolerance (HP:0003546) | 1.60522886 |
127 | Adducted thumb (HP:0001181) | 1.56727737 |
128 | Metatarsus adductus (HP:0001840) | 1.55197159 |
129 | Increased serum pyruvate (HP:0003542) | 1.54653286 |
130 | Long clavicles (HP:0000890) | 1.47569329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PHKG1 | 4.14786654 |
2 | PHKG2 | 4.14786654 |
3 | OBSCN | 3.73602689 |
4 | TTN | 3.71188957 |
5 | PDK3 | 2.63436219 |
6 | PDK4 | 2.63436219 |
7 | NTRK3 | 2.51365547 |
8 | NEK1 | 2.49699813 |
9 | LMTK2 | 2.35439235 |
10 | EPHA4 | 2.33201141 |
11 | MAP3K9 | 2.22490513 |
12 | PINK1 | 2.15978825 |
13 | MAP3K4 | 2.11197773 |
14 | MAP2K4 | 2.10397664 |
15 | PRKD3 | 1.96921111 |
16 | TRIB3 | 1.81160473 |
17 | GRK5 | 1.75035311 |
18 | PAK6 | 1.73369717 |
19 | DMPK | 1.62440581 |
20 | DAPK2 | 1.53768745 |
21 | EEF2K | 1.51083375 |
22 | STK38 | 1.49591209 |
23 | LIMK1 | 1.47798831 |
24 | PDK2 | 1.46783694 |
25 | MINK1 | 1.46199888 |
26 | NME1 | 1.45350268 |
27 | KSR2 | 1.44795196 |
28 | MAP3K7 | 1.44220265 |
29 | MARK1 | 1.41595315 |
30 | MUSK | 1.41520947 |
31 | MAP2K7 | 1.29441895 |
32 | CAMKK1 | 1.24403189 |
33 | NTRK2 | 1.19181718 |
34 | MAPK12 | 1.17634470 |
35 | NTRK1 | 1.17064758 |
36 | RIPK1 | 1.12053451 |
37 | PKN2 | 1.09857288 |
38 | TYRO3 | 1.08764736 |
39 | CCNB1 | 1.08656599 |
40 | WNK1 | 1.07883557 |
41 | PAK3 | 0.93074100 |
42 | GRK7 | 0.92598900 |
43 | CAMK4 | 0.91872090 |
44 | TAOK1 | 0.90647866 |
45 | CAMK2B | 0.89416734 |
46 | CDK5 | 0.89081075 |
47 | ERBB3 | 0.88116521 |
48 | MYLK | 0.88031981 |
49 | PIK3CA | 0.84268537 |
50 | CAMK1 | 0.83151953 |
51 | LATS2 | 0.80329286 |
52 | CDK19 | 0.79689342 |
53 | PRKCH | 0.77475591 |
54 | KSR1 | 0.76288721 |
55 | MAP3K12 | 0.75825906 |
56 | CAMK2A | 0.74925563 |
57 | CAMKK2 | 0.73570787 |
58 | CAMK2D | 0.72736970 |
59 | PRKCG | 0.72644543 |
60 | PRPF4B | 0.71813377 |
61 | BCKDK | 0.71497238 |
62 | PRKAA1 | 0.70027060 |
63 | DAPK1 | 0.69695562 |
64 | MAP2K6 | 0.67040724 |
65 | PKN1 | 0.66392546 |
66 | SGK3 | 0.65741912 |
67 | EPHA3 | 0.64438849 |
68 | CDC42BPA | 0.64209849 |
69 | RET | 0.63150376 |
70 | PDK1 | 0.63075740 |
71 | PTK2B | 0.62794196 |
72 | TIE1 | 0.59726009 |
73 | MAPK7 | 0.58776318 |
74 | DYRK1B | 0.58406655 |
75 | PRKD1 | 0.58181658 |
76 | UHMK1 | 0.57518284 |
77 | NEK9 | 0.57383047 |
78 | CAMK2G | 0.57223881 |
79 | MARK2 | 0.56877382 |
80 | STK11 | 0.56570300 |
81 | PDPK1 | 0.55816359 |
82 | PRKAA2 | 0.54929218 |
83 | MOS | 0.54851763 |
84 | PIK3CG | 0.54800234 |
85 | PLK2 | 0.53993005 |
86 | SGK1 | 0.53590011 |
87 | SGK223 | 0.53429226 |
88 | SGK494 | 0.53429226 |
89 | ROCK1 | 0.53393929 |
90 | SGK2 | 0.52603966 |
91 | ALK | 0.51020468 |
92 | PDGFRA | 0.47356941 |
93 | * RPS6KA3 | 0.47345310 |
94 | CSNK1G2 | 0.46945746 |
95 | MAPK13 | 0.46652256 |
96 | MAP3K1 | 0.45834119 |
97 | CDK15 | 0.45768741 |
98 | MAPKAPK3 | 0.44925276 |
99 | CDK18 | 0.44597224 |
100 | MET | 0.44355756 |
101 | PRKACB | 0.43895524 |
102 | ROCK2 | 0.43729339 |
103 | CASK | 0.43694194 |
104 | DAPK3 | 0.43576526 |
105 | MAP2K3 | 0.43221521 |
106 | STK38L | 0.42764148 |
107 | TRPM7 | 0.42054903 |
108 | STK24 | 0.41453213 |
109 | PRKG1 | 0.40978612 |
110 | ARAF | 0.40726802 |
111 | PRKACA | 0.40697821 |
112 | TSSK6 | 0.40427449 |
113 | MAPK10 | 0.40081370 |
114 | CDK14 | 0.39328989 |
115 | DYRK1A | 0.38258448 |
116 | AKT2 | 0.38219783 |
117 | CSNK1G3 | 0.37606812 |
118 | EPHB2 | 0.36890982 |
119 | CDK11A | 0.36649975 |
120 | MAP2K1 | 0.35921460 |
121 | CSNK1A1L | 0.35624805 |
122 | PRKACG | 0.35361147 |
123 | FER | 0.34889445 |
124 | ICK | 0.34551742 |
125 | PNCK | 0.34522710 |
126 | MAPK4 | 0.34310698 |
127 | CSNK1G1 | 0.33710476 |
128 | PRKCE | 0.31151939 |
129 | DYRK2 | 0.30052051 |
130 | RPS6KB1 | 0.26659269 |
131 | PRKDC | 0.26174472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.59400352 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.90266793 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.53272446 |
4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.50785578 |
5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.28621454 |
6 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.22477212 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.20544098 |
8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.19089201 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.11969892 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02350680 |
11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99890842 |
12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97147683 |
13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.90495160 |
14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89131938 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87827895 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.80030769 |
17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77873734 |
18 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.75140988 |
19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72238697 |
20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.69595621 |
21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67674970 |
22 | Insulin secretion_Homo sapiens_hsa04911 | 1.67168906 |
23 | Morphine addiction_Homo sapiens_hsa05032 | 1.63024589 |
24 | Salivary secretion_Homo sapiens_hsa04970 | 1.59141327 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53326265 |
26 | Renin secretion_Homo sapiens_hsa04924 | 1.44696987 |
27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.42503619 |
28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40361010 |
29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36136340 |
30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33522141 |
31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.29743066 |
32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27436467 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26836122 |
34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25660026 |
35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24729112 |
36 | Taste transduction_Homo sapiens_hsa04742 | 1.24484491 |
37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23241023 |
38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19821506 |
39 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.18492237 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14897982 |
41 | Long-term depression_Homo sapiens_hsa04730 | 1.13185187 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12578071 |
43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08653783 |
44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05391892 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04070046 |
46 | Gap junction_Homo sapiens_hsa04540 | 1.00774980 |
47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95378229 |
48 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94069848 |
49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92931994 |
50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90890894 |
51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87450209 |
52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85801137 |
53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85244730 |
54 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84391880 |
55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83721949 |
56 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83392139 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82940219 |
58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.80477810 |
59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78202951 |
60 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77195259 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76979048 |
62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76938623 |
63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76733155 |
64 | Insulin resistance_Homo sapiens_hsa04931 | 0.76078972 |
65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74759991 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74508505 |
67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73693747 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73251823 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72206788 |
70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68365863 |
71 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68054672 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67966927 |
73 | Melanogenesis_Homo sapiens_hsa04916 | 0.67633288 |
74 | Glioma_Homo sapiens_hsa05214 | 0.67600138 |
75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66118776 |
76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65258343 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64920155 |
78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64751195 |
79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63511053 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63305314 |
81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63018354 |
82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62104595 |
83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62009733 |
84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61375546 |
85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59425751 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57942715 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57740065 |
88 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57687729 |
89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57633238 |
90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56377829 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53457108 |
92 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52902458 |
93 | Lysine degradation_Homo sapiens_hsa00310 | 0.52882824 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52736493 |
95 | Tight junction_Homo sapiens_hsa04530 | 0.52275014 |
96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51171390 |
97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51018497 |
98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50960343 |
99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50033560 |
100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48067526 |
101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47083767 |
102 | Bile secretion_Homo sapiens_hsa04976 | 0.46047536 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45740796 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45488281 |
105 | Adherens junction_Homo sapiens_hsa04520 | 0.44987679 |
106 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44762704 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44278681 |
108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43495283 |
109 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43236466 |
110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43133901 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42965489 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42900285 |
113 | Axon guidance_Homo sapiens_hsa04360 | 0.42662507 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41343751 |
115 | Alcoholism_Homo sapiens_hsa05034 | 0.41019306 |
116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38014793 |
117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37507709 |
118 | Focal adhesion_Homo sapiens_hsa04510 | 0.37126712 |
119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37001174 |
120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36816581 |
121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36429277 |
122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32154413 |